About us
Epiderma®
EPIDERMA® - HOLISTICALLY FOCUSED COSMETICS THAT TAKE INTO ACCOUNT MEDICAL CONSIDERATIONS AND NATURAL INGREDIENTS
.svg)
EPIDERMA® IS A CZECH COMPANY WHICH, SINCE ITS INCEPTION, HAS BEEN A HOLISTICALLY FOCUSED COSMETICS FIRM, CONCENTRATING ON SOLVING OFTEN COMPLICATED SKIN PROBLEMS.
WHAT DOES A HOLISTIC APPROACH TO PROBLEMS SUCH AS ACNE, ECZEMA AND PSORIASIS ENTAIL?
IT INVOLVES DRAWING TOGETHER THE MEDICAL SPECIALISATION OF MUDr. JIŘÍ SKALICKÝ, WHO IN HIS MEDICAL PRACTICE DEALT SPECIFICALLY WITH DERMATOLOGY AND WHOSE APPLICATION OF NATURAL ESSENCES ENRICHED THE MEDICAL VIEW OF THE FIELD.
EPIDERMA® PRIMARILY SPECIALISES IN INNOVATION AND DEVELOPMENT IN PSORIASIS, ECZEMA, AND ACNE SOLUTIONS. ONE OF EPIDERMA'S UNDISPUTED UNIQUE FEATURES IS THE BETULDIOL® COMPOSITION. THIS COMPOSITION IS SIGNIFICANTLY ANTI-INFLAMMATORY, REGENERATIVE, AND UNIQUE IN ITS OWN WAY. THE FACT THAT IT IS THE SUBJECT OF A PATENT OF PAN-EUROPEAN IMPORTANCE IS SIGNIFICANT.
TRADITION AND EXPERIENCE – INTERNATIONAL PATENT!
EPIDERMA® čDRAWS AND BUILDS ON THE LIFELONG STUDIES AND EXPERIENCE OF ITS FOUNDER, MUDr. JIŘÍ SKALICKÝ.
DR. SKALICKÝ GRADUATED FROM CHARLES UNIVERSITY IN PRAGUE IN 1978 AND FROM EARLY ON IN HIS CAREER WAS INTERESTED IN MEDICINE’S INNOVATIVE FEATURES. IN 1992 HE WENT INTO THE PRIVATE SECTOR. HE SPENT EIGHT YEARS IN RUSSIA, WHERE HE STUDIED ALTERNATIVE MEDICINE. A SIGNIFICANT INFLUENCE ON HIS FUTURE WORK WAS A STAY IN ALTAI, A MOUNTAINOUS PART OF SIBERIA WHERE THE LOCAL FLORA HIDES UP TO 300 SPECIES OF MEDICINAL HERBS, INCLUDING CANNABIS.
HE IS THE AUTHOR AND CO-AUTHOR OF SEVERAL PATENTS OF INTERNATIONAL IMPORTANCE.
AFTER RETURNING TO THE CZECH REPUBLIC, HE DEVOTED HIMSELF INTENSIVELY TO HIS OWN RESEARCH, ALREADY FOCUSING ON PROBLEMATIC SKIN MANIFESTATIONS AND THEIR TREATMENT. HE HAS CONDUCTED MANY STUDIES ON THE EFFECTS OF HEMP OIL AND ITS INFLUENCE ON SKIN DISEASES. HE IS THE AUTHOR AND CO-AUTHOR OF SEVERAL PATENTS OF INTERNATIONAL IMPORTANCE. HE IS ONE OF A HANDFUL OF PIONEERS WHO FOUND A USE FOR HEMP (CANNABIS) OIL IN COSMETOLOGY.
IN 2007, HE BECAME INTERESTED IN DUAL (DUAL-ACTING) ANTI-INFLAMMATORY MEDICINE. PUT SIMPLY, IT RELATES TO THE INHIBITORY EFFECT OF THE PRO-INFLAMMATORY ENZYME COX (CYCLOOXYGENASE) AND THE PRO-INFLAMMATORY ENZYME LOX (LIPOOXYGENASE). HE APPLIED HIS KNOWLEDGE OF HEMP IN ONE OF HIS PATENTS WITH DUAL-ACTION ANTI-INFLAMMATORY AGENTS – CANNABIOX. AT THE TIME, IT WAS THE FIRST NATURAL PHARMACEUTICAL COMPOSITION IN THE WORLD WITH THIS EFFECT.
CANNABIDIOL ENRICHED WITH BETULIN AS A SUPERSTRUCTURE FOR COSMETICS THAT BOTH HEAL AND CURE
LATER, HE ALSO CONTRIBUTED THE FIRST PHARMACOPOEIAL STANDARD OF HEMP OIL TO THE SCIENTIFIC COMMUNITY, WHICH HAD NOT BEEN DESCRIBED UNTIL THEN. HE WAS THE FIRST TO UNIFY THE COMPOSITION OF HEMP OIL AND MARKET ITS STANDARD. HE WORKED ON THE PHARMACOPOEIA FROM 2008 TO 2010 WITH THE HELP OF THE UCT IN PRAGUE WITH ING. FRANTIŠEK KVASNIČKA, CSC. IT WAS APPROVED BY THE EUROPEAN COMMISSION IN BRUSSELS AND IS BINDING FOR ALMOST THE WHOLE WORLD.
IN 2012, MUDr. SKALICKÝ NOTED THAT CANNABIOX IS NOT ALWAYS EQUALLY EFFECTIVE AND HAS OCCASIONAL MILD ADVERSE REACTIONS. THESE FINDINGS TRIGGERED THE DEVELOPMENT OF A MORE ADVANCED AND EFFECTIVE DUAL COMPOSITION – BETULDIOL®.
THE MIXTURE OF CANNABIDIOL AND BETULIN SHOWED HIGH REGENERATIVE EFFECTS.
IN 2014, MUDr. JIŘÍ SKALICKÝ INVESTED HIS KNOW-HOW INTO EPIDERMA S.R.O., A COMPANY SPECIALISING IN THE PRODUCTION OF DERMOCOSMETICS FOR PATIENTS WITH PROBLEMATIC SKIN.
DR. SKALICKÝ HAS DEVOTED ALMOST HIS ENTIRE PROFESSIONAL LIFE TO THE EFFECT OF ACTIVE SUBSTANCES FROM CANNABIS ON DISEASED SKIN. AS A RESULT, HIS COSMETIC MIXTURES ARE OF THE HIGHEST STANDARD, AND CUSTOMERS REPEATEDLY SEEK OUT PROGRAMMES SPECIALLY TARGETED AT INDIVIDUAL SKIN TYPES FOR THEIR HEALING AND REGENERATIVE EFFECTS.